CN116888138A - 放射性药物缀合组合物及其用途 - Google Patents
放射性药物缀合组合物及其用途 Download PDFInfo
- Publication number
- CN116888138A CN116888138A CN202180092527.XA CN202180092527A CN116888138A CN 116888138 A CN116888138 A CN 116888138A CN 202180092527 A CN202180092527 A CN 202180092527A CN 116888138 A CN116888138 A CN 116888138A
- Authority
- CN
- China
- Prior art keywords
- conjugate
- peptide
- amino acid
- protein
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119555P | 2020-11-30 | 2020-11-30 | |
| US63/119,555 | 2020-11-30 | ||
| PCT/US2021/061186 WO2022115778A1 (en) | 2020-11-30 | 2021-11-30 | Radiopharmaceutical conjugate compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116888138A true CN116888138A (zh) | 2023-10-13 |
Family
ID=81753691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180092527.XA Pending CN116888138A (zh) | 2020-11-30 | 2021-11-30 | 放射性药物缀合组合物及其用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230158179A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4251639A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023551539A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116888138A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022115778A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119874832A (zh) * | 2025-01-13 | 2025-04-25 | 重庆医科大学 | 一种新型多肽荧光探针的制备方法及应用 |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023283882A1 (en) * | 2022-06-10 | 2025-01-30 | Peking University | Trifunctional compound and use thereof |
| CN120091830A (zh) * | 2022-08-24 | 2025-06-03 | 苏州创胜医药集团有限公司 | 使用抗cldn18.2抗体-放射性核素缀合物的非侵入性方法 |
| CN117645652A (zh) * | 2022-09-02 | 2024-03-05 | 核欣(苏州)医药科技有限公司 | 环肽及其制备方法、包括其的复合物、及其用途 |
| US20260083865A1 (en) * | 2022-09-07 | 2026-03-26 | 3B Pharmaceuticals Gmbh | Prostate specific membrane antigen (psma) ligands and use thereof |
| JP2025532958A (ja) * | 2022-09-29 | 2025-10-03 | ペプチドリーム株式会社 | EphA2結合保留ペプチド及びそれを含む組成物 |
| WO2024073622A2 (en) * | 2022-09-29 | 2024-04-04 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting ephrin type-a receptor 2 and uses thereof |
| WO2024183634A1 (en) * | 2023-03-09 | 2024-09-12 | Norroy Bioscience Co., Ltd. | Radiolabeled antibody conjugates and uses thereof |
| JPWO2024195709A1 (cg-RX-API-DMAC7.html) * | 2023-03-17 | 2024-09-26 | ||
| CN118754936A (zh) * | 2023-03-27 | 2024-10-11 | 晶核生物医药科技(南京)有限公司 | 环状多肽类化合物及其应用 |
| EP4692105A1 (en) * | 2023-03-27 | 2026-02-11 | Bivision Pharmaceuticals, Inc | Cyclic polypeptide compound and use thereof |
| KR20260009883A (ko) * | 2023-05-24 | 2026-01-20 | 베이징 창핑 래보러토리 | 신규 삼관능 화합물 및 이의 용도 |
| EP4719498A1 (en) * | 2023-05-31 | 2026-04-08 | Full-Life Technologies UK Limited | Radioligands for targeting cell surface receptors and uses thereof |
| WO2024254339A2 (en) * | 2023-06-07 | 2024-12-12 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting glypican-3 and uses thereof |
| JP2026521249A (ja) * | 2023-06-14 | 2026-06-29 | マリアナ オンコロジー インコーポレーテッド | Dll3標的化ペプチド及びその構築物 |
| CR20260011A (es) * | 2023-06-14 | 2026-05-15 | Mariana Oncology Inc | Péptidos dirigidos a dll3 y sus construcciones |
| AU2024304266A1 (en) * | 2023-06-14 | 2025-12-04 | Mariana Oncology Inc. | Dll3 targeting peptides and constructs thereof |
| UY40854A (es) * | 2023-08-15 | 2025-02-28 | Novartis Ag | Péptidos cíclicos dirigidos a fap y conjugados de los mismos |
| TW202517674A (zh) | 2023-10-19 | 2025-05-01 | 德商拜耳廠股份有限公司 | 抗gpc3抗體及其放射性結合物 |
| WO2025117586A1 (en) * | 2023-11-27 | 2025-06-05 | Mariana Oncology Inc. | Dll3 targeting peptides and constructs thereof |
| WO2025137443A1 (en) | 2023-12-22 | 2025-06-26 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting somatostatin receptors and uses thereof |
| WO2025179168A1 (en) * | 2024-02-22 | 2025-08-28 | Mariana Oncology Inc. | Synthesis of dll3-binding peptides |
| CN119119174B (zh) * | 2024-09-12 | 2025-08-08 | 重庆医科大学附属第二医院 | 一种靶向caix和fap的化合物、其核素标记物、制法和应用 |
| WO2026128542A1 (en) * | 2024-12-11 | 2026-06-18 | Rayzebio, Inc. | Radiopharmaceutical compositions targeting glypican-3 and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017512A (en) | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
| US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
| CN106573959B (zh) | 2014-06-06 | 2022-03-25 | 慕尼黑工业大学 | 修饰的环五肽及其用途 |
| US10421783B2 (en) * | 2016-02-19 | 2019-09-24 | The Curators Of The University Of Missouri | Prostate-specific membrane antigen (PSMA) targeting peptides |
| AU2017281940C1 (en) | 2016-06-24 | 2024-11-07 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| US11638764B2 (en) | 2018-11-08 | 2023-05-02 | Indi Molecular, Inc. | Theranostic capture agents, compositions, and methods of using and making |
| PL3997103T3 (pl) * | 2019-07-08 | 2025-03-24 | 3B Pharmaceuticals Gmbh | Związki zawierające ligand białka aktywującego fibroblasty i ich zastosowanie |
| CN118955620A (zh) * | 2019-07-08 | 2024-11-15 | 3B制药有限公司 | 包含成纤维细胞活化蛋白配体的化合物及其用途 |
-
2021
- 2021-11-30 CN CN202180092527.XA patent/CN116888138A/zh active Pending
- 2021-11-30 EP EP21899224.6A patent/EP4251639A1/en active Pending
- 2021-11-30 WO PCT/US2021/061186 patent/WO2022115778A1/en not_active Ceased
- 2021-11-30 JP JP2023533236A patent/JP2023551539A/ja active Pending
-
2022
- 2022-11-17 US US17/989,479 patent/US20230158179A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119874832A (zh) * | 2025-01-13 | 2025-04-25 | 重庆医科大学 | 一种新型多肽荧光探针的制备方法及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230158179A1 (en) | 2023-05-25 |
| WO2022115778A1 (en) | 2022-06-02 |
| EP4251639A1 (en) | 2023-10-04 |
| JP2023551539A (ja) | 2023-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230158179A1 (en) | Radiopharmaceutical conjugate compositions and uses thereof | |
| US11814447B2 (en) | Peptide ligands for binding to EphA2 | |
| KR102754019B1 (ko) | Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드 | |
| JP7387440B2 (ja) | Mt1-mmpに結合するためのペプチドリガンド | |
| CN112585156A (zh) | 用于结合psma的肽配体 | |
| CN112533937A (zh) | 用于结合cd38的肽配体 | |
| KR20160042871A (ko) | 폴리펩티드의 효소적 콘쥬게이션 | |
| US20240148721A1 (en) | Discrete peg constructs | |
| WO2022115799A1 (en) | Radiopharmaceutical conjugates targeting guanylyl cyclase c, and compositions and uses thereof | |
| JP2021501201A (ja) | ステープルペプチドの細胞内送達のためのポリペプチド接合体 | |
| US20240100203A1 (en) | Novel cxcr4-targeting compounds | |
| IL325021A (en) | Glypican-3-targeting peptide compositions and uses thereof | |
| KR20260022328A (ko) | 글리피칸-3을 표적화하는 방사성제약 조성물 및 그의 용도 | |
| KR20250078956A (ko) | 에프린 유형-a 수용체 2를 표적화하는 방사성제약 조성물 및 그의 용도 | |
| US20250222146A1 (en) | Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof | |
| KR20250134731A (ko) | Epha2-결합 펜딩 펩티드 및 이를 포함하는 조성물 | |
| WO2025137443A1 (en) | Radiopharmaceutical compositions targeting somatostatin receptors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |